Insights & Publications

Welcome to the new Insights & Publications

This site provides access to McKinsey & Company's latest thinking with articles, reports, video, and other content from McKinsey Quarterly, the McKinsey Global Institute (MGI), and McKinsey practices.


Registered users of mckinseyquarterly.com and MGI have been automatically transferred, and existing e-mail subscriptions are unaffected. If you are not registered and would like access to all of our content and mailings, we invite you to complete a brief, free registration.


For more information about the site, please visit our FAQ section.

Article

The new value at stake in regulation

Escalating value at risk from government regulation clearly has a place on the agendas of most CEOs.

January 2010 | byRobin Nuttall and Sergio Sandoval

The expanding role of goverments in the marketplace has become a hot topic in many executive suites around the world. But how much value is actually at stake from state intervention in the wake of the financial crisis of 2008? The answer, according to our analysis, is close to $800 billion a year of earnings before interest, taxes, depreciation, and amortization (EBITDA) worldwide—on top of around $2.8 trillion on the table before the crisis.

Regulation’s impact varies by industry: half of the new value at stake is in banking and insurance, 15 percent in the automotive industry, and the remaining 35 percent scattered among other sectors. In banking and insurance, the crisis has added close to $400 billion to the industry EBITDA affected by government intervention and regulation, for a total of $970 billion (exhibit). This means that two-thirds of the sector’s profits are now at stake.

Exhibit

Value at stake from regulation

Government regulatory intervention since the economic crisis began has increased the value at stake across industries.

The huge regulatory impact of the crisis in just a few sectors doesn’t mean that executives in other ones can relax. Telcos, transport and logistics companies, energy providers, retailers, pharma companies, and health care providers have long been subject to extensive government intervention. These industries continue to represent most of the regulatory value at stake around the world. Indeed, with a total of some $3.6 trillion a year on the table, an effective strategy for engaging government clearly has a place on the agendas of most CEOs.

About the authors

Robin Nuttall is a principal in McKinsey’s London office, and Sergio Sandoval is a consultant in the Brussels office.

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Strategy Practice.